Kenvue Inc. operates as a consumer health company worldwide. The company operates through three segments: Self Care, Skin Health and Beauty, and Essential Health. The Self Care segment offers cough, cold and allergy, pain care, digestive health, smoking cessation, and other products under the Tylenol, Nicorette, and Zyrtec brands. The Skin Health and Beauty segment provides face and body care, hair care, and sun and other care products under the Neutrogena, Aveeno, and OGX brand names. The Essential Health segment offers oral and baby, women's health, and wound care products under the Listerine, Johnson's, Band-Aid, and Stayfree brands. The company was incorporated in 2022 and is headquartered in Skillman, New Jersey. Kenvue Inc. operates as a subsidiary of Johnson & Johnson.

Kenvue Inc.

Net Sales

Net Sales %Chg

Net Sales Common Size

Cost of Sales

Cost of Sales %Chg

Cost of Sales Common Size

Gross Profit

Gross Profit %Chg

Gross Profit Common Size

Selling, General, and Administrative Expenses

Selling, General, and Administrative Expenses %Chg

Selling, General, and Administrative Expenses Common Size

Restructuring Expenses

Restructuring Expenses %Chg

Restructuring Expenses Common Size

Impairment Charges

Impairment Charges %Chg

Impairment Charges Common Size

Other Operating Expense, Net

Other Operating Expense, Net %Chg

Other Operating Expense, Net Common Size

Operating Income

Operating Income %Chg

Operating Income Common Size

Other Expense, Net

Other Expense, Net %Chg

Other Expense, Net Common Size

Interest Expense, Net

Interest Expense, Net %Chg

Interest Expense, Net Common Size

Income Before Taxes

Income Before Taxes %Chg

Income Before Taxes Common Size

Provision for Taxes

Provision for Taxes %Chg

Provision for Taxes Common Size

Net Income

Net Income %Chg

Net Income Common Size

Basic

Basic %Chg

Basic Common Size

Diluted

Diluted %Chg

Diluted Common Size

Total Revenues

Total Revenues %Chg

Total Revenues Common Size

Gross Profit Margin

Gross Profit Margin %Chg

Gross Profit Margin Common Size

Selling, General & Administrative Expenses

Selling, General & Administrative Expenses %Chg

Selling, General & Administrative Expenses Common Size

Other Operating Expenses

Other Operating Expenses %Chg

Other Operating Expenses Common Size

Operating Profit

Operating Profit %Chg

Operating Profit Common Size

Operating Margin

Operating Margin %Chg

Operating Margin Common Size

Interest Expense

Interest Expense %Chg

Interest Expense Common Size

Non-Operating Income

Non-Operating Income %Chg

Non-Operating Income Common Size

Total Non-Operating Income

Total Non-Operating Income %Chg

Total Non-Operating Income Common Size

Income Before Provision for Income Taxes

Income Before Provision for Income Taxes %Chg

Income Before Provision for Income Taxes Common Size

Provision for Income Taxes

Provision for Income Taxes %Chg

Provision for Income Taxes Common Size

Consolidated Net Income

Consolidated Net Income %Chg

Consolidated Net Income Common Size

Net Income Attributable to Common Shareholders

Net Income Attributable to Common Shareholders %Chg

Net Income Attributable to Common Shareholders Common Size

Basic EPS

Basic EPS %Chg

Basic EPS Common Size

Diluted EPS

Diluted EPS %Chg

Diluted EPS Common Size

Basic Weighted Average Shares Outstanding

Basic Weighted Average Shares Outstanding %Chg

Basic Weighted Average Shares Outstanding Common Size

Total Shares Outstanding

Total Shares Outstanding %Chg

Total Shares Outstanding Common Size

Diluted Weighted Average Shares Outstanding

Revenue

EBIT

EBITDA

CapEx

Net Interest Income

Assets

Adjusted EBITDA

Adjusted Net Income

Net Revenue

Average Assets

Adjusted EBIT

Adjusted Revenue

Adjusted EBT

Adjusted Funds From Operations

Income Statement	LTM
Total Revenues	15,006
Total Revenues %Chg	-2.9%
Net Sales
Cost of Sales	6,281
Cost of Sales
Gross Profit	8,725
Gross Profit
Gross Profit Margin	58.1%
Selling, General & Administrative Expenses	6,078
Selling, General, and Administrative Expenses
Other Operating Expenses	285
Restructuring Expenses
Impairment Charges
Other Operating Expense, Net
Operating Profit	2,362
Operating Income
Operating Margin	15.7%
Interest Expense	-376
Interest Expense, Net
Non-Operating Income	-68
Other Expense, Net
Total Non-Operating Income	-444
Income Before Provision for Income Taxes	1,918
Income Before Taxes
Provision for Income Taxes	485
Provision for Taxes
Consolidated Net Income	1,433
Net Income
Net Income Attributable to Common Shareholders	1,433
Net Income
Basic EPS	0.8
Diluted EPS	0.8
Basic Weighted Average Shares Outstanding	1,916.8
Total Shares Outstanding	1,915.8
Diluted Weighted Average Shares Outstanding	1,926.3
EBITDA	2,931
Effective Tax Rate	25.3%